AmerisourceBergen Acquires PharmaLex from AUCTUS in €1.28bn Transaction
December 31, 2022
AmerisourceBergen Corporation acquired a majority stake in PharmaLex from funds advised by AUCTUS Capital Partners AG in a transaction that closed at year-end 2022 for approximately EUR 1.28 billion. PharmaLex, a Germany-headquartered provider of regulatory, clinical development and pharmacovigilance services to the life sciences industry, was grown under AUCTUS through a buy-and-build program of 38 add-ons and will expand AmerisourceBergen's global pharmaceutical solutions.
- Buyers
- AmerisourceBergen Corporation
- Targets
- PharmaLex
- Sellers
- Funds advised by AUCTUS Capital Partners AG
- Industry
- Healthcare Services
- Location
- Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
PharmaLex Acquires Arbour Group from Keystone Capital
February 12, 2020
Healthcare Services
The PharmaLex Group has acquired Arbour Group, LLC from Keystone Capital. The acquisition expands PharmaLex’s regulatory compliance, quality management and connected health capabilities and strengthens its presence in the United States.
-
PharmaLex Group Merges with NeoHealthHub Limited
October 13, 2022
Healthcare Services
PharmaLex Group has merged with UK-based NeoHealthHub Limited to strengthen PharmaLex’s market access and data capabilities in the UK and build a pan‑European market access practice. NeoHealthHub, headquartered in Lutterworth, Leicestershire, employs around 50 people and will expand PharmaLex’s local market access, data and capability development offerings across major European markets.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
Pfizer's Hospital Business Acquires Arixa Pharmaceuticals
October 22, 2020
Pharmaceuticals
Pfizer’s Hospital Business acquired Arixa Pharmaceuticals to advance development of Arixa’s lead oral prodrug ARX-1796, a potential oral beta-lactamase inhibitor + antibiotic combination. Financial terms were not disclosed; Arixa was a virtual, asset-light company based in Palo Alto and was advised by Four Oaks Partners on the transaction.
-
Actylis Acquires Pharm-Rx
October 7, 2024
Pharmaceuticals
Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.
-
Bruker Corporation Acquires PhenomeX Inc.
August 17, 2023
Biotechnology
Bruker Corporation agreed to acquire PhenomeX Inc. in an all-cash transaction valued at roughly $108 million (purchase price $1.00 per share). PhenomeX — formed from the combination of Berkeley Lights and IsoPlexis and provider of single-cell biology instruments, software and reagents — will be folded into a Bruker subsidiary, marking Bruker’s entry into single-cell biology research tools and complementing its spatial biology offerings.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.